Deep remission in inflammatory bowel disease: looking beyond symptoms
Abstract
Inflammatory bowel diseases (IBD) are chronic and disabling conditions. Accumulating evidence indicates that we need to look beyond clinical symptoms as current therapeutic strategies have not modified the course of IBD. Therapeutic goals for IBD have evolved from a mere control of symptoms to mucos …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Antibodies
Monoclonal
Colitis
biomarkers / analysis
c-reactive protein / analysis
remission induction / methods*
anti-inflammatory agents / therapeutic use
pmid:23354742
doi:10.1007/s11894-013-0315-7
camille zallot
laurent peyrin-biroulet
adalimumab
humanized / therapeutic use
ulcerative* / diagnosis
ulcerative* / drug therapy
ulcerative* / physiopathology
crohn disease* / diagnosis
crohn disease* / drug therapy
crohn disease* / physiopathology
Access
Citation
ID:
265834
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
265834
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet